Loss of heterozygosity on murine chromosome 6 in two-stage carcinogenesis: Evidence for a conserved tumor suppressor gene

Oncogene

Volumn 14, Issue 1, 1997, Pages 109-114

  Zenklusen, Jean C ^a   Hodges, Leslie C ^a   Conti, Claudio J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Human chromosome 7; Mitotic recombination; Skin tumors; Trisomy; Tumor suppressor gene

Indexed keywords

MICROSATELLITE DNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHEMICAL CARCINOGENESIS; CHROMOSOME 6; CONTROLLED STUDY; FEMALE; GENETIC CONSERVATION; HETEROZYGOSITY LOSS; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

ANIMALIA; MURINAE;

EID: 0031029909     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1200806     Document Type: Article

References (45)

1. Abrahamson GM, Rack K, Oscier DG, Fitchett M, Buckle VJ and Wainscoat JS. (1993). Am. J. Hematol., 42, 171-176.
2. Aldaz CM, Conti CJ, Klein-Szanto AJP and Slaga TJA. (1986). Cancer Genet. Cytogenet., 20, 223-229.
3. Aldaz CM, Trono D, Larcher F, Slaga TJ and Conti CJ. (1989). Mol. Carcinog., 2, 22-26.
4. An H-X, Niederacher D, Beckmann MW, Göhring U-J, Scharl A, Picard F, van Roeyen C, Schnüren H-G and Bender HG. (1995). Int. J. Cancer (Pred. Oncol.), 64, 291-297.
5. Atkin NB and Baker MC. (1991). Cancer Genet. Cytogenet., 52, 113-121.
6. Atkin NB and Baker MC. (1993). Cancer Genet. Cytogenet., 67, 123-125.
7. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA and Struhl K. (Eds.) (1992). Current Protocols in Molecular Biology. Greene Publishing and John Wiley & Sons: New York, pp. 2.1.2-2.1.5.
8. Bianchi AB, Navone NM, Aldaz CM and Conti CJ. (1991). Proc. Natl. Acad. Sci. USA, 88, 7590-7594.
9. Bowden GT, Schneider B, Domann R and Kulesz-Martin M. (1994). Cancer Res., 54 (7 Suppl), 1882s-1885s.
10. Boyd JA and Barrett JC. (1991). Basic Life Sci. 57, 183-196.
11. Canzian F, Ushijima T, Serikawa T, Wakabayashi K, Sugimura T and Nagao M. (1994). Cancer Res., 54, 6315-6317.
12. Conti CJ, Bianchi AB, Navone NM, Ruggieri BA, Caamano J, Goodrow T and Klein-Szanto AJP. (1992). Prog. Clin. Biol. Res., 376, 85-101.
13. Conti CJ. (1994). Handbook of mouse mutation with skin and hair abnormalities, Sundberg JP. (ed.). CRC Press: Boca Raton. pp. 39-46.
14. Copeland NG, Gilbert DJ, Jenkins NA, Nadeau JH, Eppig JT, Maltais LJ, Miller JC, Dietrich WF, Steen RG, Lincoln SE, Weaver A, Joyce DC, Merchant M, Wessel M, Katz H, Stein LD, Reeve MP, Daly MJ, Dredge RD, Marquis A, Goodman N and Lander ES. (1993). Science, 262, 67.
15. Davis LM, Caspary WJ, Sakallah SA, Maronpot R, Wiseman R, Barrett JC, Elliot R and Hozier J. (1994). Carcinogenesis, 15, 1637-1645.
16. Dietrich WF, Miller JC, Steen RG, Merchant M, Damron D, Nahf R, Gross A, Joyce DC, Wessel M and Dredge RD. (1994). Nature Genet., 7, 220-245.
17. DiGiovanni J. (1991). Prog. Exp. Tumor Res., 33, 192-229.
18. Emerit I and Lahoud-Maghani M. (1989). Mutat. Res., 214, 97-104.
19. Hegi ME, Devereux TR, Dietrich WF, Cochran CJ, Lander ES, Foley JF, Maronpot RR, Anderson MW and Wiseman RW. (1994). Cancer Res., 54, 6257-6264.
20. James CD, Carlbom E, Nordenskjold M, Collins VP and Cavenee WK. (1989). Proc. Natl. Acad. Sci. USA, 86, 2858-2862.
21. Kemp JP, Fee F and Balmain A. (1993). Cancer Res., 53, 6022-6027.
22. Kere J, Ruutu T, Davies KA, Roninson IB, Watkins PC, Winqvist R and de la Chapelle A. (1989). Blood, 73, 230-234.
23. Kibbelaar RE, Mulder JW, Dreef EJ, Van KH, Fibbe WE, Wessels JW, Beverstock GC, Haak HL and Kluin PM. (1993). Blood, 82, 904-913.
24. Lehman TA, Reddel R, Peiifer AM, Spillare E, Kaighn ME, Weston A, Gerwin BI and Harris CC. (1991). Environ. Health Perspect., 93, 133-134.
25. Loeb LA. (1994). Cancer Res., 54, 5059-5063.
26. Mao L, Lee DJ, Tockman MS, Erozan YS, Askin F and Sidransky D. (1994). Proc. Natl. Acad. Sci. USA, 91, 9871-9875.
27. Miyasaka K, Ohtake K, Nomura K, Kanda H, Kominami R, Miyashita N and Kitagawa T. (1995). Mol. Carcinog., 13, 37-43.
28. Miller DR, Viaje A, Aldaz CM, Conti CJ and Slaga TJ. (1987). Cancer Res., 47, 1935-1940.
29. Mori N, Yokota J, Oshimura M, Cavenee WK, Mizoguchi H, Noguchi M, Shimosato Y, Sugimura T and Terada M. (1989). Cancer Res., 49, 5130-5135.
30. Neubauer A, Neubauer B, He M, Effert P, Iglehart D, Frye RA and Liu ET. (1992). Oncogene, 7, 1019-1025.
31. Osella P, Carlson A, Wyandt H and Milunsky A. (1992). Cancer Genet. Cytogenet., 59, 73-78.
32. Ohsumi T, Okazaki Y, Okuizumi H, Shibata K, Hanami T, Mizuno Y, Takahara T, Sasaki N, Ueda M, Muramatsu M. (1995). Biochem. Biophys. Res. Commun., 212, 632-639.
33. Sasaki K, Bertrand O, Nakazawa H, Fitzgerald DJ, Mironov N and Yamasaki H. (1995). Cancer Res., 55, 3513-3516.
34. Schreiber G and Dubeau L. (1990). Amer. J. Pathol., 13, 653-658.
35. Shiraishi Y. (1985). EMBO J, 4, 2553-2560.
36. Weinberg RA. (1991). Tumor suppressor genes. Science, 254, 1134-1146.
37. Whitehead Institute/MIT Center for Genome Research. (1994). Genetic Map of the Mouse. Database Release 7.
38. Yuspa SH, Dlugosz AA, Cheng CK, Denning MF, Tennenbaum T, Glick AB and Weinberg WC. (1994). Invest. Dermatol., 103(5 Suppl), 90s-95s.
39. Zar JH. (1991). Biostatistical Analysis. Prentice-Hall: Englewood Cliffs, NJ, pp. 102-121.
40. Zenklusen JC, Barrett JC, Oshimura M, and Conti CJ. (1994a). Oncogene, 9, 2817-2825.
41. Zenklusen JC, Bièche I, Lidereau R and Conti CJ. (1994b). Proc. Nat. Acad. Sci. USA, 91, 12155-12158.
42. Zenklusen JC, Thompson JC, Klein-Szanto AJP and Conti CJ. (1995a). Cancer Res., 55, 1347-1350.
43. Zenklusen JC, Thompson JC, Troncoso P, Kagan J and Conti CJ. (1994b). Cancer Res., 54, 6370-6373.
44. Zenklusen JC, Weitzel JN, Ball H and Conti CJ. (1995c). Oncogene, 11, 359-363.
45. Zenklusen JC and Conti CJ. (1996). Mol. Carcinog., 15, 167-175.